Tandutinib inhibits FMS receptor signalling, and macrophage and osteoclast formation in vitro.

Article Details

Citation

Copy to clipboard

Brownlow N, Vaid M, Dibb NJ

Tandutinib inhibits FMS receptor signalling, and macrophage and osteoclast formation in vitro.

Leukemia. 2008 Jul;22(7):1452-3. doi: 10.1038/sj.leu.2405085. Epub 2008 Jan 10.

PubMed ID

18185521 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Tandutinib